Genmab A/S (GMAB) Stock Chart & Stock Price History → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free GMAB Stock Alerts $29.34 -0.47 (-1.58%) (As of 05:17 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Genmab A/S Stock Price Performance5 Day Performance-2.13%1 Month Performance+2.73%3 Month Performance+0.62%6 Month Performance-7.00%Year-To-Date Performance-7.85%1 Year Performance-29.81% Receive GMAB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Genmab A/S and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Weiss RatingsWho are Nvidia’s Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.I call these Nvidia’s “Silent Partners.” GMAB Stock Chart for Thursday, May, 23, 2024 GMAB Chart by TradingView Genmab A/S Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/22/2024$29.15$29.81+2.26%$30.06$29.66383,700 shs$19.71 billion05/21/2024$29.69$29.15-1.82%$29.44$29.13335,499 shs$19.27 billion05/20/2024$29.98$29.69-0.97%$30.01$29.63247,010 shs$19.63 billion05/17/2024$29.65$29.98+1.11%$30.00$29.52375,160 shs$19.82 billion05/16/2024$30.22$29.65-1.89%$29.83$29.50587,476 shs$19.61 billion05/15/2024$29.53$30.22+2.34%$30.41$29.73514,376 shs$19.98 billion Get the Latest News and Ratings for GMAB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Genmab A/S and its competitors with MarketBeat's FREE daily newsletter. 05/14/2024$29.16$29.53+1.27%$29.53$29.24652,226 shs$19.53 billion05/13/2024$28.84$29.16+1.11%$29.52$28.72688,692 shs$19.28 billion05/10/2024$28.81$28.84+0.10%$28.93$28.71259,970 shs$19.07 billion05/09/2024$28.80$28.81+0.03%$28.94$28.66330,417 shs$19.05 billion05/08/2024$29.29$28.80-1.67%$29.25$28.74592,927 shs$19.04 billion05/07/2024$29.03$29.29+0.90%$29.36$28.89676,857 shs$19.37 billion05/06/2024$29.72$29.03-2.32%$29.29$28.89406,779 shs$19.20 billion05/03/2024$27.72$29.72+7.22%$29.92$29.46718,302 shs$19.65 billion05/02/2024$28.75$27.72-3.58%$28.27$27.42667,528 shs$18.33 billion05/01/2024$27.69$28.75+3.83%$29.00$27.97876,260 shs$19.01 billion04/30/2024$28.57$27.69-3.08%$28.40$27.66933,125 shs$18.31 billion04/29/2024$28.15$28.57+1.49%$28.65$28.01591,815 shs$18.89 billion04/26/2024$27.46$28.15+2.51%$28.18$27.91338,746 shs$18.61 billion04/25/2024$28.47$27.46-3.55%$27.80$27.43436,363 shs$18.16 billion04/24/2024$28.56$28.47-0.32%$28.76$28.09456,119 shs$18.83 billion04/23/2024$28.97$28.56-1.42%$29.04$28.54559,802 shs$18.88 billion04/22/2024$28.70$28.97+0.94%$29.21$28.72452,366 shs$19.16 billion04/19/2024$28.33$28.70+1.31%$28.81$28.45361,029 shs$18.98 billion04/18/2024$28.53$28.33-0.70%$28.62$28.29243,953 shs$18.73 billion04/17/2024$29.43$28.53-3.06%$28.84$28.44358,638 shs$18.86 billion04/16/2024$29.51$29.43-0.27%$29.61$28.77342,399 shs$19.46 billion04/15/2024$29.26$29.51+0.85%$29.67$29.27544,079 shs$19.51 billion04/12/2024$29.74$29.26-1.61%$29.79$29.15413,219 shs$19.33 billion04/11/2024$29.95$29.74-0.70%$30.11$29.42327,641 shs$19.65 billion04/10/2024$29.97$29.95-0.07%$30.12$29.54375,459 shs$19.79 billion04/09/2024$29.86$29.97+0.37%$30.00$29.63385,110 shs$19.80 billion04/08/2024$29.76$29.86+0.34%$29.94$29.67222,156 shs$19.73 billion04/05/2024$29.65$29.76+0.37%$29.88$29.61237,451 shs$19.66 billion04/04/2024$29.30$29.65+1.19%$30.50$29.63517,560 shs$19.59 billion04/03/2024$29.96$29.30-2.20%$29.68$29.17782,237 shs$19.36 billion04/02/2024$30.27$29.96-1.02%$30.31$29.75281,668 shs$19.80 billion04/01/2024$29.91$30.27+1.20%$30.34$29.70362,330 shs$20.00 billion03/29/2024$29.91$29.91$30.56$29.84361,406 shs$19.76 billion03/28/2024$30.63$29.91-2.35%$30.56$29.84361,389 shs$19.76 billionNvidia’s Quiet $1 Trillion Pivot (Ad)Nvidia recently added $277 billion in market cap … IN ONE DAY.Find out details on these three critical Nvidia partners immediately.03/27/2024$30.83$30.63-0.65%$30.63$30.11319,427 shs$20.24 billion03/26/2024$29.98$30.83+2.84%$31.02$30.68538,488 shs$20.37 billion03/25/2024$29.92$29.98+0.20%$30.10$29.89332,598 shs$19.81 billion03/22/2024$29.56$29.92+1.22%$30.27$29.83358,837 shs$19.77 billion03/21/2024$29.44$29.56+0.41%$29.93$29.49369,800 shs$19.53 billion03/20/2024$29.64$29.44-0.67%$29.57$29.28286,675 shs$19.45 billion03/19/2024$29.69$29.64-0.17%$29.68$29.36326,680 shs$19.58 billion03/18/2024$29.94$29.69-0.84%$30.01$29.68411,189 shs$19.62 billion03/15/2024$30.30$29.94-1.19%$30.22$29.691.01 million shs$19.78 billion03/14/2024$31.34$30.30-3.32%$31.26$30.11631,143 shs$20.02 billion03/13/2024$31.43$31.34-0.29%$31.88$31.27368,541 shs$20.71 billion03/12/2024$31.68$31.43-0.79%$31.48$31.05749,959 shs$20.77 billion03/11/2024$30.30$31.68+4.55%$31.81$30.961.22 million shs$20.93 billion03/08/2024$29.41$30.30+3.03%$30.31$29.84492,492 shs$20.02 billion03/07/2024$28.86$29.41+1.91%$29.52$29.23254,754 shs$19.43 billion03/06/2024$28.75$28.86+0.38%$29.19$28.86479,237 shs$19.07 billion03/05/2024$28.51$28.75+0.84%$28.90$28.50618,549 shs$19.00 billion03/04/2024$29.29$28.51-2.66%$28.81$28.39553,391 shs$18.84 billion03/01/2024$27.77$29.29+5.47%$29.48$28.58551,844 shs$19.35 billion02/29/2024$27.67$27.77+0.36%$28.26$27.76893,184 shs$18.35 billion02/28/2024$29.05$27.67-4.75%$28.34$27.511.75 million shs$18.28 billion02/27/2024$29.40$29.05-1.19%$29.25$28.85435,996 shs$19.19 billion02/26/2024$29.16$29.40+0.82%$29.46$29.14893,501 shs$19.43 billion02/23/2024$29.11$29.16+0.17%$29.31$29.05594,294 shs$19.27 billion02/22/2024$28.95$29.11+0.55%$29.19$28.96450,479 shs$19.23 billion Related Companies: Teva Pharmaceutical Industries Stock Chart Alnylam Pharmaceuticals Stock Chart BeiGene Stock Chart BioMarin Pharmaceutical Stock Chart Viatris Stock Chart Sarepta Therapeutics Stock Chart United Therapeutics Stock Chart Dr. Reddy's Laboratories Stock Chart Catalent Stock Chart Roivant Sciences Stock Chart Receive GMAB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Genmab A/S and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:GMAB) was last updated on 5/23/2024 by MarketBeat.com Staff From Our Partners[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaProtect Your Bank Account Before It’s Too LateWeiss RatingsMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceWrite this ticker symbol down…StocksToTrade**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsThis could mean the end of the U.S dollar…Colonial MetalsThis military-backed stock “owns” AI marketPorter & CompanyBuy this small stock before coming AI Tidal WaveChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genmab A/S Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.